Target intelligence / Profile preview

Peri-infarct depolarization (PID)

Target
PID
Molecular classification
Other (pathophysiological electrical event), Spreading depression phenomenon
01

Overview

Peri-infarct depolarizations are recurring, spreading waves of sustained neuronal and glial depolarization that occur in regions surrounding a focal cerebral infarct (the penumbra) or traumatized cortex. They are triggered by anoxic release of potassium and excitatory amino acids from infarcted tissue and propagate across the cortex at a rate of approximately 3 mm/min. These events induce metabolic stress, expression of immediate early genes and stress proteins, and can result in hypoxic injury and stepwise expansion of the infarct core if perfusion is inadequate[1][2][5]. Suppression of peri-infarct depolarizations using NMDA/non-NMDA receptor antagonists or sodium channel blockers has been shown to minimize infarct size and improve outcomes in preclinical models, making the process a therapeutic target for neuroprotection in stroke and related brain injuries[1][3].

Other names
Peri-infarct depolarizationsPIDsspreading depression (in post-stroke context)SD-like depolarizations
02

Mechanism of action

Suppression of glutamate-mediated excitotoxic depolarizations; Prevention of electrical propagation of depolarizations; Reduction in expression of stress response proteins and infarct size[1][3]

03

Biological functions

Electrochemical disturbanceInduction of immediate early genes and stress responsesTriggering tissue hypoxia in penumbral regionsAggravation of infarct expansion[1][2][5]
04

Disease associations

Neurodegenerative disease (primarily acute ischemic stroke)Secondary injury in traumatic brain injury or subarachnoid hemorrhage[2][5]
05

Safety considerations

Therapeutic challenge: direct suppression of PIDs requires drugs with CNS penetrance and safety in acute neurological injuryRisk of immunosuppression, psychiatric symptoms, or other adverse CNS effects from NMDA antagonists
06

Interacting drugs

NMDA receptor antagonists (e.g., ketamine, memantine)[1]

3 more in the full profile.

07

Biomarkers

Immediate early gene expressionStress protein inductionChanges in diffusion-weighted MRI in penumbral regions[1]Electrocorticographic delta activity[3]

Beyond the preview

Go deeper on Peri-infarct depolarization (PID).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peri-infarct depolarization (PID).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call